SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-151302
Filing Date
2014-04-22
Accepted
2014-04-21 20:40:40
Documents
5
Period of Report
2014-06-04
Effectiveness Date
2014-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d710203ddef14a.htm DEF 14A 935160
2 GRAPHIC g710203g36p28.jpg GRAPHIC 5826
3 GRAPHIC g710203pc_pg001a.jpg GRAPHIC 1256
4 GRAPHIC g710203pc_pg001b.jpg GRAPHIC 6671
5 GRAPHIC g710203pc_pg002.jpg GRAPHIC 1492
  Complete submission text file 0001193125-14-151302.txt   957780
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26727 | Film No.: 14775078
SIC: 2834 Pharmaceutical Preparations